[1]
RAVINANDAN AP et al. 2025. RETHINKING PRESCRIPTIONS: DESIGNING A CLINICAL PROCESS MAP TO MITIGATE DAPAGLIFLOZIN-INDUCED PRESCRIBING CASCADES. Asian Journal of Pharmaceutical and Clinical Research. 18, 5 (May 2025), 1–4. DOI:https://doi.org/10.22159/ajpcr.2025v18i5.54320.